Lingfeng He (Weiru He)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Venues

Cell death and differentiation

Oncogene

Cell death & disease

Molecular cancer research : MCR

Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Sep 01 2003 - Jan 01 2009

China

PHD :: Biochemistry and Molecular biology

Ocean University of China Sep 01 1990 - Jul 01 1994

China

BSC :: Marine biology

Publications

Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation (2024)
Yu Du, Yu Zhou, Xinyu Yan, Fei-Yan Pan, Lingfeng He, Zhigang Guo, Zhigang Hu
APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell death and differentiation 31 (4) (2024)
Meina Wang, Kaili Long, Enjie Li, Lulu Li, Binghua Li, Shusheng Ci, Lingfeng He, Feiyan Pan, Zhigang Hu, Zhigang Guo
Correction: DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation. Oncogene (2023)
Ting Wu, Hongqiao Zhu, Miaomiao Zhang, Yuling Sun, Yongjing Yang, Lili Gu, Jing Zhang, Dan Mu, Congye Wu, Zhigang Hu, Longwei Jiang, Shaochang Jia, Ying Zhang, Lingfeng He, Fei-Yan Pan, Zhigang Guo
FEN1 inhibitor synergizes with low-dose camptothecin to induce increased cell killing via the mitochondria mediated apoptotic pathway. Gene therapy (2021)
Kaili Long, Lili Gu, Lulu Li, Ziyu Zhang, Enjie Li, Yilan Zhang, Lingfeng He, Feiyan Pan, Zhigang Guo, Zhigang Hu
Small-molecule inhibition of APE1 induces apoptosis, pyroptosis, and necroptosis in non-small cell lung cancer. Cell death & disease 12 (6) (2021)
Meina Wang, Kaili Long, Enjie Li, Lulu Li, Binghua Li, Shusheng Ci, Lingfeng He, Feiyan Pan, Zhigang Hu, Zhigang Guo
DNA polymerase beta modulates cancer progression via enhancing CDH13 expression by promoter demethylation. Oncogene 39 (33) (2020)
Jing Zhang, Li Jing, Subee Tan, Er-Ming Zeng, Yingbo Lin, Lingfeng He, Zhigang Hu, Jianping Liu, Zhigang Guo
Inhibition of miR-1193 leads to synthetic lethality in glioblastoma multiforme cells deficient of DNA-PKcs. Cell death & disease 11 (7) (2020)
Meina Wang, Enjie Li, Lin Lin, Alagamuthu Karthick Kumar, Feiyan Pan, Lingfeng He, Jing Zhang, Zhigang Hu, Zhigang Guo
Enhanced Activity of Variant DNA Polymerase β (D160G) Contributes to Cisplatin Therapy by Impeding the Efficiency of NER. Molecular cancer research : MCR 17 (10) (2019)
Hong Zhu, Congye Wu, Ting Wu, Wen Xia, Shusheng Ci, Lingfeng He, Yilan Zhang, Lulu Li, Shiying Zhou, Jing Zhang, Ashlin M Edick, Anna Zhang, Fei-Yan Pan, Zhigang Hu, Zhigang Guo
Inhibition of AKT Sensitizes Cancer Cells to Antineoplastic Drugs by Downregulating Flap Endonuclease 1. Molecular cancer therapeutics 18 (12) (2019)

Lingfeng He.css-eqlu8i{font-size:small;padding-left:4px;} (Weiru He)

Publication Activity (10 Years)

Top Topics

Top Venues

Lingfeng He (Weiru He)